Literature DB >> 23196345

Effect of glucosylceramide on the biophysical properties of fluid membranes.

Ana R P Varela1, Amélia M P S Gonçalves da Silva, Alexander Fedorov, Anthony H Futerman, Manuel Prieto, Liana C Silva.   

Abstract

Glucosylceramide (GlcCer), a relevant intermediate in the pathways of glycosphingolipid metabolism, plays key roles in the regulation of cell physiology. The molecular mechanisms by which GlcCer regulates cellular processes are unknown, but might involve changes in membrane biophysical properties and formation of lipid domains. In the present study, fluorescence spectroscopy, confocal microscopy and surface pressure-area (π-A) measurements were used to characterize the effect of GlcCer on the biophysical properties of model membranes. We show that C16:0-GlcCer has a high tendency to segregate into highly ordered gel domains and to increase the order of the fluid phase. Monolayer studies support the aggregation propensity of C16:0-GlcCer. π-A isotherms of single C16:0-GlcCer indicate that bilayer domains, or crystal-like structures, coexist within monolayer domains at the air-water interface. Mixtures with POPC exhibit partial miscibility with expansion of the mean molecular areas relative to the additive behavior of the components. Moreover, C16:0-GlcCer promotes morphological alterations in lipid vesicles leading to formation of flexible tubule-like structures that protrude from the fluid region of the bilayer. These results support the hypothesis that alterations in membrane biophysical properties induced by GlcCer might be involved in its mechanism of action.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23196345     DOI: 10.1016/j.bbamem.2012.11.018

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  13 in total

1.  Synthesis of a novel photoactivatable glucosylceramide cross-linker.

Authors:  Monique Budani; Murugesapillai Mylvaganam; Beth Binnington; Clifford Lingwood
Journal:  J Lipid Res       Date:  2016-07-13       Impact factor: 5.922

2.  Pathological α-syn aggregation is mediated by glycosphingolipid chain length and the physiological state of α-syn in vivo.

Authors:  Kristina Fredriksen; Stefanos Aivazidis; Karan Sharma; Kevin J Burbidge; Caleb Pitcairn; Friederike Zunke; Eilrayna Gelyana; Joseph R Mazzulli
Journal:  Proc Natl Acad Sci U S A       Date:  2021-12-14       Impact factor: 12.779

3.  Lipidomic analysis of human tear fluid reveals structure-specific lipid alterations in dry eye syndrome.

Authors:  Sin Man Lam; Louis Tong; Bastien Reux; Xinrui Duan; Andrea Petznick; Siew Sian Yong; Cynthia Boo Shiao Khee; Martin J Lear; Markus R Wenk; Guanghou Shui
Journal:  J Lipid Res       Date:  2013-11-28       Impact factor: 5.922

4.  Glucosylceramide Reorganizes Cholesterol-Containing Domains in a Fluid Phospholipid Membrane.

Authors:  Ana R P Varela; André Sá Couto; Aleksander Fedorov; Anthony H Futerman; Manuel Prieto; Liana C Silva
Journal:  Biophys J       Date:  2016-02-02       Impact factor: 4.033

5.  Intermedilysin cytolytic activity depends on heparan sulfates and membrane composition.

Authors:  Gediminas Drabavicius; Dirk Daelemans
Journal:  PLoS Genet       Date:  2021-02-12       Impact factor: 5.917

6.  Altering the sphingolipid acyl chain composition prevents LPS/GLN-mediated hepatic failure in mice by disrupting TNFR1 internalization.

Authors:  M Ali; J Fritsch; H Zigdon; Y Pewzner-Jung; S Schütze; A H Futerman
Journal:  Cell Death Dis       Date:  2013-11-21       Impact factor: 8.469

7.  Glucosylceramide modifies the LPS-induced inflammatory response in macrophages and the orientation of the LPS/TLR4 complex in silico.

Authors:  Edouard Mobarak; Liliana Håversen; Moutusi Manna; Mikael Rutberg; Malin Levin; Rosie Perkins; Tomasz Rog; Ilpo Vattulainen; Jan Borén
Journal:  Sci Rep       Date:  2018-09-11       Impact factor: 4.379

8.  Mixing brain cerebrosides with brain ceramides, cholesterol and phospholipids.

Authors:  Emilio J González-Ramírez; Félix M Goñi; Alicia Alonso
Journal:  Sci Rep       Date:  2019-09-16       Impact factor: 4.379

9.  Altered Sphingolipids Metabolism Damaged Mitochondrial Functions: Lessons Learned From Gaucher and Fabry Diseases.

Authors:  Margarita Ivanova
Journal:  J Clin Med       Date:  2020-04-14       Impact factor: 4.241

10.  Mice defective in interferon signaling help distinguish between primary and secondary pathological pathways in a mouse model of neuronal forms of Gaucher disease.

Authors:  Ayelet Vardi; Shifra Ben-Dor; Soo Min Cho; Ulrich Kalinke; Julia Spanier; Anthony H Futerman
Journal:  J Neuroinflammation       Date:  2020-09-07       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.